Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Non-Current Assets (2016 - 2025)

Aethlon Medical filings provide 15 years of Non-Current Assets readings, the most recent being $1.4 million for Q1 2025.

  • On a quarterly basis, Non-Current Assets fell 30.22% to $1.4 million in Q1 2025 year-over-year; TTM through Mar 2025 was $6.5 million, a 27.65% decrease, with the full-year FY2025 number at $1.4 million, down 30.22% from a year prior.
  • Non-Current Assets hit $1.4 million in Q1 2025 for Aethlon Medical, down from $1.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.6 million in Q4 2022 to a low of $304986.0 in Q3 2021.
  • Median Non-Current Assets over the past 5 years was $1.7 million (2024), compared with a mean of $1.6 million.
  • Biggest five-year swings in Non-Current Assets: soared 734.03% in 2022 and later tumbled 30.22% in 2025.
  • Aethlon Medical's Non-Current Assets stood at $706042.0 in 2021, then skyrocketed by 261.48% to $2.6 million in 2022, then decreased by 14.29% to $2.2 million in 2023, then dropped by 28.82% to $1.6 million in 2024, then fell by 9.46% to $1.4 million in 2025.
  • The last three reported values for Non-Current Assets were $1.4 million (Q1 2025), $1.6 million (Q4 2024), and $1.7 million (Q3 2024) per Business Quant data.